Albers is accredited by AACSB International - The Association to Advance Collegiate Schools of Business. As of April 2011, less than five percent of the world’s business schools and less than one third of U.S. business schools have achieved business accreditation from AACSB.
David Shoultz is a Deputy Director in the Global Health Program at the Bill & Melinda Gates Foundation – he specifically works with Program Strategy Teams focused on enteric diseases, pneumonia and related respiratory conditions, malaria, and other neglected infectious diseases. For the past two years, he has also served as the relationship manager for PATH – one of the largest grantees of the foundation. He is responsible for overseeing operations and finance for the four (4) strategic program teams within the ID division, as well as for strategy and portfolio management. David’s work focuses on strategy, operations, and finance, and he also acts as a liaison with product development partnerships, other grantees, and external partners. In this capacity, he is a Board member at OneWorld Health, the drug development affiliate of PATH.
David received his MS and PhD in epidemiology at the University of Washington School of Public Health and Community Medicine where his research focused on the epidemiology of human papillomavirus infections. He is currently a member of the affiliate faculty for the Departments of Global Health and Epidemiology at the University of Washington, and is also a faculty member at the Albers School of Business and Economics of Seattle University, where he teaches in the Healthcare Leadership Executive MBA Program.
Prior to joining the foundation, David worked with a number of clinical research organizations participating in the development of new medicines. His positions at these companies included Executive Director of Business Development at PPD, Vice President of Business Development at Ockham Ventures, and Vice President of Business Development at PRA International. Prior to joining the Gates Foundation, he was most recently Vice President of Business Development at Biomedical Systems, where he was responsible for management of business development for most of North America, Japan, and Asia. David received his PhD (Epidemiology), MS (Epidemiology), and BSN from the University of Washington. His MBA is from Seattle University.
In addition to his role at the Gates foundation, David is on the Board of the Geneva Foundation, a private, non-profit organization created in 1993 with the sole purpose to support and promote the advancement of military medicine. He also serves as the inaugural Chair of the Scientific Advisory Committee for the Geneva foundation.